British Patient Capital
Investor profile
Venture capital
British Patient Capital has backed 19 European tech companies across 23 funding rounds between 2021 and 2025, joining rounds totalling €1.7B. Most active in Healthtech and Software. Data as of 4 Nov 2026.
Also recorded as: British PatientCapital
Deals
23
distinct rounds
Companies
19
backed
Active span
2021–2025
5 yrs
Total round €
€1.7B
sum of rounds joined
Deals by year
distinct rounds / yearBritish Patient Capital — deals by year — interactive chart.
Data table
| British Patient Capital — deals by year | |
|---|---|
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 3 |
Top sectors
by dealsBritish Patient Capital — top sectors — interactive chart.
Data table
| British Patient Capital — top sectors | |
|---|---|
| Healthtech | 10 |
| Software | 3 |
| Fintech | 3 |
| Semiconductors | 3 |
| Deeptech | 2 |
| Hardware | 1 |
| Cybersecurity | 1 |
Stages
by dealsBritish Patient Capital — stages — interactive chart.
Data table
| British Patient Capital — stages | |
|---|---|
| Series B | 9 |
| Series C | 5 |
| Series D+ | 5 |
| Series A | 3 |
| Other | 1 |
Countries
by dealsBritish Patient Capital — countries — interactive chart.
Data table
| British Patient Capital — countries | |
|---|---|
| UK | 23 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Oxford Science Enterprises4
- Cambridge Innovation Capital3
- IQ Capital3
- Northern Gritstone3
- Pfizer Ventures3
- ABN AMRO2
- AlbionVC2
- Andera Partners2
- BGF2
- Canaan Partners2
- Dawn Capital2
- Earlybird Venture Capital2
- Evolution Equity Partners2
- HSBC2
- IP Group2
- Latitude2
- Molten Ventures2
- Parkwalk Advisors2
- Prosperity7 Ventures2
- Warburg Pincus2
- 3B Future Health Fund1
- 83North1
- ABC Impact1
- Advent Life Sciences1
- Aphelion1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quantexa | UK | 3 | €412M |
| Pragmatic | UK | 2 | €245M |
| Thought Machine | UK | 1 | €177M |
| Quell Therapeutics | UK | 1 | €138M |
| Grey Wolf Therapeutics | UK | 2 | €87M |
| Proximie | UK | 1 | €77M |
| Maxion Therapeutics | UK | 1 | €66M |
| Microbiotica | UK | 1 | €61M |
| Form3 | UK | 1 | €54M |
| Quantum Motion | UK | 1 | €48M |
| Oxford Quantum Circuits | UK | 1 | €45M |
| Phagenesis | UK | 1 | €39M |
| Nucleome Therapeutics | UK | 1 | €38M |
| Epsilogen | UK | 1 | €37M |
| Iceotope | UK | 1 | €35M |
| Accurx | UK | 1 | €32M |
| GaN Devices | UK | 1 | €30M |
| Stream (formerly Wagestream) | UK | 1 | €20M |
| CyberSmart | UK | 1 | €14M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Pragmatic | Series D+ | €213M | 2023-12 |
| Thought Machine | Series C | €177M | 2021-11 |
| Quantexa | Series D+ | €164M | 2025-03 |
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Quantexa | Series D+ | €130M | 2021-07 |
| Quantexa | Series D+ | €118M | 2023-04 |
| Proximie | Series C | €77M | 2022-06 |
| Maxion Therapeutics | Series A | €66M | 2025-03 |
| Microbiotica | Series B | €61M | 2022-03 |
| Form3 | Series C | €54M | 2024-09 |